Exploring new routes for neuroprotective drug development in traumatic brain injury (Q46152263)

20 December 2017

title

Exploring new routes for neuroprotective drug development in traumatic brain injury (English)

1 reference

20 December 2017

author name string

T Janowitz

series ordinal

1

1 reference

20 December 2017

D K Menon

series ordinal

2

1 reference

20 December 2017

language of work or name

English

0 references

publication date

1 April 2010

1 reference

20 December 2017

Science Translational Medicine

published in

1 reference

20 December 2017

volume

2

1 reference

20 December 2017

issue

27

1 reference

20 December 2017

page(s)

27rv1

1 reference

20 December 2017

Clinical trials in head injury

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

A systematic review of brain injury epidemiology in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Projections of global mortality and burden of disease from 2002 to 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Traumatic brain injury research priorities: the Conemaugh International Brain Injury Symposium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Management of severe head injury: institutional variations in care and effect on outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Why do neuroprotective drugs that are so promising in animals fail in the clinic? An industry perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Multifunctional drugs for head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Prognosis and clinical trial design in traumatic brain injury: the IMPACT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

New insights into the causes and therapy of cerebral vasospasm following subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Evaluation of pharmacological treatment strategies in traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Combination therapies for traumatic brain injury: prospective considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Concentrations of fosfomycin in the cerebrospinal fluid of neurointensive care patients with ventriculostomy-associated ventriculitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Blood-brain barrier transport of morphine in patients with severe brain trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Investigation of the effect of chlormethiazole on cerebral chemistry in neurosurgical patients: a combined study of microdialysis and a neuroprotective agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Pharmacokinetics of sevoflurane uptake into the brain and body

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Effective use of microdosing and Positron Emission Tomography (PET) studies on new drug discovery and development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Positron emission tomography and single-photon emission computed tomography in central nervous system drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Neuroscience and accelerator mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Big physics, small doses: the use of AMS and PET in human microdosing of development drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Arteriojugular endothelin-1 gradients in aneurysmal subarachnoid haemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Inflammation in human brain injury: intracerebral concentrations of IL-1alpha, IL-1beta, and their endogenous inhibitor IL-1ra

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Inflammatory response after ischemic stroke: a USPIO-enhanced MRI study in patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Intrinsic activated microglia map to the peri-infarct zone in the subacute phase of ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Positron emission tomography imaging of neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

beta-amyloid (Abeta)42(43), abeta42, abeta40 and apoE immunostaining of plaques in fatal head injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Traumatic axonal damage in the brain can be detected using beta-APP immunohistochemistry within 35 min after head injury to human adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Amyloid-beta dynamics correlate with neurological status in the injured human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Evaluation of topiramate neuroprotective effect in severe TBI using microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Brain metabolic and hemodynamic effects of cyclosporin A after human severe traumatic brain injury: a microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Early metabolic characteristics of lesion and nonlesion tissue after head injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Hyperventilation following head injury: effect on ischemic burden and cerebral oxidative metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Effect of hyperventilation on cerebral blood flow in traumatic head injury: clinical relevance and monitoring correlates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Effect of hyperoxia on regional oxygenation and metabolism after severe traumatic brain injury: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Unique challenges in clinical trials in traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Impact of intracranial pressure and cerebral perfusion pressure on severe disability and mortality after head injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Focal lesions in acute mild traumatic brain injury and neurocognitive outcome: CT versus 3T MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Correlation of postmortem MRI and CT appearances with neuropathology in brain trauma: a comparison of two methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

White matter integrity and cognition in chronic traumatic brain injury: a diffusion tensor imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Analysis of acute traumatic axonal injury using diffusion tensor imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Structural dissociation of attentional control and memory in adults with and without mild traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

NNZ-2566: a Gly-Pro-Glu analogue with neuroprotective efficacy in a rat model of acute focal stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Pharmacokinetic modelling of interleukin-1 receptor antagonist in plasma and cerebrospinal fluid of patients following subarachnoid haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Uptake of estradiol or progesterone into the CSF following intranasal and intravenous delivery in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Cerebrospinal fluid progesterone in pregnant women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

The interleukin-1 signalling pathway in astrocytes: a key contributor to inflammation in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Neuromonitoring in the intensive care unit. I. Intracranial pressure and cerebral blood flow monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Microdialysis in the human brain and its potential role in the development and clinical assessment of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Imaging after brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Pharmacologic treatment of acute traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Effects of pegorgotein on neurologic outcome of patients with severe head injury. A multicenter, randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Neuroprotection in traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

EBIC-guidelines for management of severe head injury in adults. European Brain Injury Consortium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

Diffusion tensor imaging during recovery from severe traumatic brain injury and relation to clinical outcome: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000330

10.1126/SCITRANSLMED.3000330

21 January 2018

Identifiers

DOI

1 reference

20 December 2017

PubMed ID

20393189

1 reference

20 December 2017